Evaluation of envelope domain III-based single chimeric tetravalent antigen and monovalent antigen mixtures for the detection of anti-dengue antibodies in human sera
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Evaluation of envelope domain III-based single chimeric tetravalent antigen and monovalent antigen mixtures for the detection of anti-dengue antibodies in human sera ; volume:11 ; number:1 ; day:15 ; month:3 ; year:2011 ; pages:1-6 ; date:12.2011
BMC infectious diseases ; 11, Heft 1 (15.3.2011), 1-6, 12.2011
- Creator
-
Batra, Gaurav
- Contributor
-
Nemani, Satish K.
Tyagi, Poornima
Swaminathan, Sathyamangalam
Khanna, Navin
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-11-64
- URN
-
urn:nbn:de:1111-2016030261218
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Batra, Gaurav
- Nemani, Satish K.
- Tyagi, Poornima
- Swaminathan, Sathyamangalam
- Khanna, Navin
- SpringerLink (Online service)
Other Objects (12)
Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Chimeric Antigen Receptor T-Cell Therapy
Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
Immunogenicity of a novel tetravalent dengue envelope protein domain III-based antigen in mice
Chimeric antigen receptor–based therapies beyond cancer
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Engineering better chimeric antigen receptor T cells
Optimization of chimeric antigen receptor (CAR) therapy
Cancer-testis antigen specific chimeric antigen receptor T cells for cancer immunotherapy
A chimeric antigen receptor against prostate-specific membrane antigen, a tumor vasculature target
Effectors of the Future: Universal Chimeric Antigen Receptor
Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Chimeric Antigen Receptor T-Cell Therapy
Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
Immunogenicity of a novel tetravalent dengue envelope protein domain III-based antigen in mice
Chimeric antigen receptor–based therapies beyond cancer
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Engineering better chimeric antigen receptor T cells
Optimization of chimeric antigen receptor (CAR) therapy
Cancer-testis antigen specific chimeric antigen receptor T cells for cancer immunotherapy
A chimeric antigen receptor against prostate-specific membrane antigen, a tumor vasculature target
Effectors of the Future: Universal Chimeric Antigen Receptor
Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Chimeric Antigen Receptor T-Cell Therapy
Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
Immunogenicity of a novel tetravalent dengue envelope protein domain III-based antigen in mice
Chimeric antigen receptor–based therapies beyond cancer
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Engineering better chimeric antigen receptor T cells
Optimization of chimeric antigen receptor (CAR) therapy
Cancer-testis antigen specific chimeric antigen receptor T cells for cancer immunotherapy
A chimeric antigen receptor against prostate-specific membrane antigen, a tumor vasculature target